Cargando…
Metastatic Renal Cell Carcinoma with Level IV Thrombus: Contemporary Management with Complete Response to Neoadjuvant Targeted Therapy
Renal cell carcinoma, particularly the most common clear cell type, is one of the most aggressive of urological cancers with significant risk of metastatic spread. It also has a propensity for venotropism with a proportion of tumors developing thrombi up to the right atrium. The response with newly...
Autores principales: | Bhat, Abhishek, Nahar, Bruno, Venkatramani, Vivek, Banerjee, Indraneel, Kryvenko, Oleksandr N., Parekh, Dipen J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6437729/ https://www.ncbi.nlm.nih.gov/pubmed/31001447 http://dx.doi.org/10.1155/2019/7102504 |
Ejemplares similares
-
Corrigendum to “Metastatic Renal Cell Carcinoma with Level IV Thrombus: Contemporary Management with Complete Response to Neoadjuvant Targeted Therapy”
por: Bhat, Abhishek, et al.
Publicado: (2019) -
Focal therapy for localized prostate cancer – Current status
por: Atluri, Shrikanth, et al.
Publicado: (2022) -
Complete response of renal cell carcinoma vena cava tumor thrombus to neoadjuvant immunotherapy
por: Labbate, Craig, et al.
Publicado: (2019) -
Primitive neuroectodermal tumor of kidney with Level III inferior vena cava thrombus
por: Ansari, Haris, et al.
Publicado: (2019) -
Pathological complete response of renal cell carcinoma with vena cava tumor thrombus to neoadjuvant TKI/IO combination therapy
por: Hara, Takuto, et al.
Publicado: (2021)